IRadimed Corporation
IRMD
$92.50
$1.291.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.05M | 23.61M | 22.48M | 21.18M | 20.66M |
| Total Depreciation and Amortization | 1.63M | 1.43M | 1.17M | 980.90K | 794.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.11M | 5.35M | 5.65M | 3.03M | 2.97M |
| Change in Net Operating Assets | -2.65M | -1.44M | -4.34M | -184.10K | 2.72M |
| Cash from Operations | 27.14M | 28.95M | 24.95M | 25.01M | 27.14M |
| Capital Expenditure | -2.02M | -4.47M | -7.76M | -10.26M | -12.93M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -572.10K | -502.10K | -656.10K | -800.70K | -876.30K |
| Cash from Investing | -2.59M | -4.97M | -8.42M | -11.06M | -13.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 25.70K | 25.70K |
| Repurchase of Common Stock | -2.63M | -2.49M | -2.56M | -783.90K | -772.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.83M | -15.43M | -15.04M | -8.39M | -8.12M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.46M | -17.93M | -17.60M | -9.14M | -8.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -1.00K | -1.00K | 0.00 | 0.00 |
| Net Change in Cash | 6.08M | 6.04M | -1.07M | 4.81M | 4.46M |